During the past decade, Atlantic Urology Medical Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlantic Urology Medical Group" #1 sponsor was "Ferring Pharmaceuticals" with 3 trials, followed by "Novartis Pharmaceuticals" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored, "ICOS Corporation" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlantic Urology Medical Group" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator, "Procter and Gamble" with 1 trials as a collaborator and "Therion Biologics Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Atlantic Urology Medical Group" are "Prostate Cancer" (7 trials), "Benign Prostatic Hyperplasia" (2 trials), "Interstitial Cystitis" (2 trials), "Overactive Bladder" (2 trials) and "Urinary Incontinence" (2 trials). Many other conditions were trialed in "Atlantic Urology Medical Group" in a lesser frequency.

Most popular intervention types in "Atlantic Urology Medical Group" are "Drug" (13 trials), "Biological" (3 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Degarelix" (2 trials), "Behavioral therapy" (1 trials), "Botulinum toxin type A" (1 trials) and "Darifenacin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Atlantic Urology Medical Group" are 9 trials for "Male" genders and 7 trials for "All" genders.

Currently, there are NaN active trials in "Atlantic Urology Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Atlantic Urology Medical Group, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Atlantic Urology Medical Group, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".